US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Genelux Corporation (GNLX)
Genelux Corporation (GNLX) ニュース

GNLX

Genelux (GNLX)

Genelux Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNLX

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/25	06 : 19	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GNLX	Genelux Corporation
2024/05/24	21 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GNLX	Genelux Corporation
2024/05/24	21 : 00	GlobeNewswire Inc.	Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants	NASDAQ:GNLX	Genelux Corporation
2024/05/24	05 : 59	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GNLX	Genelux Corporation
2024/05/24	05 : 01	GlobeNewswire Inc.	Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants	NASDAQ:GNLX	Genelux Corporation
2024/05/16	06 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNLX	Genelux Corporation
2024/05/10	05 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNLX	Genelux Corporation
2024/05/10	05 : 25	GlobeNewswire Inc.	Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates	NASDAQ:GNLX	Genelux Corporation
2024/05/10	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GNLX	Genelux Corporation
2024/04/01	20 : 00	GlobeNewswire Inc.	Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:GNLX	Genelux Corporation
2024/02/14	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GNLX	Genelux Corporation
2024/02/05	23 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GNLX	Genelux Corporation
2024/02/03	06 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GNLX	Genelux Corporation
2024/02/03	06 : 36	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:GNLX	Genelux Corporation
2024/02/03	06 : 06	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GNLX	Genelux Corporation
2023/12/19	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNLX	Genelux Corporation
2023/12/16	06 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GNLX	Genelux Corporation
2023/12/15	10 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNLX	Genelux Corporation
2023/12/15	10 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNLX	Genelux Corporation
2023/12/14	06 : 59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GNLX	Genelux Corporation
2023/12/14	06 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GNLX	Genelux Corporation
2023/12/12	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GNLX	Genelux Corporation
2023/12/09	07 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNLX	Genelux Corporation
2023/12/08	07 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GNLX	Genelux Corporation
2023/11/27	21 : 00	GlobeNewswire Inc.	Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer	NASDAQ:GNLX	Genelux Corporation
2023/11/25	03 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GNLX	Genelux Corporation
2023/11/23	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GNLX	Genelux Corporation
2023/11/18	07 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GNLX	Genelux Corporation
2023/11/15	07 : 50	GlobeNewswire Inc.	Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates	NASDAQ:GNLX	Genelux Corporation
2023/11/15	06 : 24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GNLX	Genelux Corporation

Showing the most relevant articles for your search:NASDAQ:GNLX

1 2 3 4 5 次へ >>

BMO Balanced ETF

ESE Entertainment

Region Wallonne 1.568% C...

Healios K K (PK)

Vanquis BKG (PK)

Skinbiotherapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約